DRUG | SUPPLIED | DOSE | COMMENTS |
---|---|---|---|
DOPAMINE (Paeds) (Intropin) Mechanism of action: Dopamine is a beta adrenergic agonist with dopaminergic effects (in low dose), beta 1 effects (in medium dose) and alpha effects (in high dose). Ref: 37, 44 Last update: 2019-01-17 |
injection: 40 mg/mL 5 mL vial (SAP); 1.6 mg/mL 250 mL bag; 3.2 mg/mL 250 mL bag. Standard concentrations for Critical Care (commercially available): 1.6 mg/mL in D5W PFS (1600 mcg/mL) 3.2 mg/mL in D5W PFS (3200 mcg/mL) pH = 2.5 - 4.5 Osmolality (40 mg/mL) = 619, (3.2 mg/mL) = 295 Protect from light, change solution at 96 hours. Discard solution if yellow-brown discoloration occurs. Use Alaris Pump to determine infusion rate. AND Confirm with the following calculation: Infusion rate (mL/h) = Dose (mcg/kg/min) x Weight (kg) x 60 (min/h) divided by Concentration (mcg/mL). |
Hypotension, Infants, Children and Adults: 0.5 - 20 mcg/kg/min Low Dose: 1 -5 mcg/kg/min. (Dopaminergic, increase renal blood flow) Medium Dose: 5-15 mcg/kg/min. (Beta-Adrenergic, increase HR and contractility) High Dose: > 15 mcg/kg/min. (Alpha-Adrenergic, increase peripheral vasoconstriction) Maximum Dose: 50 mcg/kg/min Protect from light, change solution at 96 hours. Discard solution if yellow-brown discoloration occurs. |
For use in critical care areas only (up to 5 mcg/kg/min. may be given on the oncology unit) Correct hypovolemia before use. Use cautiously with phenytoin as hypotension and bradycardia may be exacerbated. Adverse effects include tachycardia, arrhythmia, hypotension, hypertension, peripheral gangrene. These can occur with larger doses. For treatment of extravasation see phentolamine protocol on ePOPS Standard Prescription: dopamine __mcg/kg/min continuous IV infusion |